Hisamitsu To Go Private For Long-Term Growth Through $2.6bn MBO

 
• By Lisa Takagi
  
Hisamitsu goes private
Japanese firm's broad strategy will remain unchanged after the MBO led by CEO Kazuhide Nakatomi (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Japan

More from Focus On Asia